Navigation Links
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011
Date:8/25/2011

he Quarter 67

7.7 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q2 2011 68

7.7.1 Respiratory – Deals of the Quarter 69

7.8 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q2 2011 70

7.8.1 Gastrointestinal – Deals of the Quarter 71

7.9 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q2 2011 72

7.9.1 Dermatology – Deals of the Quarter 73

7.10 Pharmaceuticals & Healthcare, Global, Musculoskeletal Deals, Q2 2011 74

7.10.1 Musculoskeletal – Deals of the Quarter 75

8 Deal Summary by Geography 76

8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q2 2011 76

8.1.1 North America – Deals of the Quarter 77

8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q2 2011 78

8.2.1 Europe – Deals of the Quarter 79

8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q2 2011 80

8.3.1 Asia-Pacific – Deals of the Quarter 81

8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q2 2011 82

8.4.1 Rest of the World – Deals of the Quarter 83

9 Pharmaceuticals & Healthcare, Global, Top Advisors 84

9.1 Pharmaceutical & Healthcare, Global Top Financial Advisors, M&A, Last One Year 84

9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 85

10 Further Information 86

10.1 Methodology 86

10.2 About GlobalData 86

10.3 Contact Us 87

10.4 Disclosure information 87

10.5 Disclaimer 87

List of Tables

Table 1: Pharmaceutical & Healthcare, Global, Deal Summary, Number of Deals and Deal Values (US$m), Q2 2010 - Q2 2011 10

Table 2: Pharmaceutical & Healthcare, Global, Number Of Deals and Deal Values (%), Q2 2011 11

Table 3: Pharmaceutical & Healthcare, Global, Top Deals, Q2 2011 12


'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Kimberly-Clark Health Care Announces Strategic Green Partnerships, Commitment to Reducing Medical Waste
2. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
3. MGT Capital Investments, Inc. Provides Update on Recent Developments
4. Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities
5. Apax Partners, CPPIB and PSP Investments to Acquire Kinetic Concepts, Inc. for $68.50 per Share
6. Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years
7. MGT Capital Investments Receives NYSE Amex Listing Deficiency Notification
8. Michigan Pre-Seed Capital Fund Reports Investments Totaling $2.5 Million in 2010
9. PharmaNets Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
10. Pittsburgh Life Sciences Greenhouse and Innovation Works Announce Investments in Ib2C™
11. Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Novagali Pharma, an,emerging pharmaceutical company specialized in ophthalmology,presents ... trial,positive results from the Phase III clinical study ... at the,XIV Afro-Asian Congress of ophthalmology (AACO) held ... , VKC is a severe form of chronic ...
... Interim results in a randomized phase II/III ... 26, 2007 /PRNewswire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI) ... that treatment with pixantrone (BBR,2778) resulted in ... mitoxantrone induced significant cardiac damage.,The studies compared ...
Cached Medicine Technology:Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 2Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 3Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... McCullers, MD, was recently invited to submit a ... Reviews Microbiology , one of the world,s foremost ... disease specialist, and chair of the Department of ... Center, analyzed the epidemiology and microbiology of co-infections ... well as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... many as 10 million older Americans suffer from depression, ... , However, new research a project that followed ... six years found that Internet use among the ... than 30 percent. , "That,s a very strong effect," ... telecommunication, information studies and media who led the project. ...
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
(Date:4/17/2014)... A. Arias, M.D., Ph.D., at The University of Texas ... new superbug that caused a bloodstream infection in a ... issue of The New England Journal of Medicine ... class of highly-resistant bacteria known as methicillin-resistant Staphylococcus ... of hospital and community-associated infections. The superbug has also ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2
... may not be any more effective than giving them ... study.// ,Researchers studied 100 children with upper ... a common ingredient found in over-the-counter cough medicines. Another ... 34 children were given a placebo. ,Results of ...
... that’s responsible for controlling the activated leukocyte cell adhesion molecule ... cells stay clumped together. The gene is less active in ... don’t result in a spreading of the disease. Researchers speculate ... to more easily separate and migrate to other areas of ...
... the immune system may play a key role in women ... percent of all conceptions // fail, and around 1 percent ... many of the cases are due to fetal abnormalities, others ... research links the reproductive hormone secretion system to the immune ...
... SARS vaccine may be on the horizon. Researchers from ... a study involving eight African green monkeys. Four of ... using an intranasal vaccine made from a parainfluenza vaccine ... express a major antigen of the coronavirus that causes ...
... is a drop in blood pressure, say researchers, according ... on the association between blood pressure and Alzheimer’s disease ... on blood pressure variations before and after a diagnosis ... who were 75 or older. The participants had no ...
... down the progression of HIV, according to new research. Researchers ... progression of this deadly disease. Past studies have indicated that ... HIV. However researchers recently conducted a study to determine if ... included 1,078 pregnant women who were infected with HIV. The ...
Cached Medicine News:
9 mm diameter pigtail curved blunt probes. Stainless steel. Round knurled handle with polished finish. Includes pre-cut polyethylene tubes. Overall length: 5.9 inches....
Yag Laser System SYL is compact and light-weight. It is CE Mark approved according to MDD....
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with thumb catch lock and dull finish....
... evaluation has a choice of 4 ... automatic creation 'horse-shoe' diagrams, automatic color ... calculation of color confusion index (CCI), ... (OD, OS, OU) and test or ...
Medicine Products: